1
|
Figueiredo CS, Rocha AMND, Silva LMCRDCN, Faria MDSPCD, Tavares TMTVDC, Mota MDCOC. Acute kidney injury: the experience of a tertiary center of Pediatric Nephrology. J Bras Nefrol 2024; 46:e20240012. [PMID: 38748945 DOI: 10.1590/2175-8239-jbn-2024-0012en] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2024] [Accepted: 03/12/2024] [Indexed: 07/15/2024] Open
Abstract
INTRODUCTION Acute kidney injury (AKI) is an abrupt deterioration of kidney function. The incidence of pediatric AKI is increasing worldwide, both in critically and non-critically ill settings. We aimed to characterize the presentation, etiology, evolution, and outcome of AKI in pediatric patients admitted to a tertiary care center. METHODS We performed a retrospective observational single-center study of patients aged 29 days to 17 years and 365 days admitted to our Pediatric Nephrology Unit from January 2012 to December 2021, with the diagnosis of AKI. AKI severity was categorized according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. The outcomes considered were death or sequelae (proteinuria, hypertension, or changes in renal function at 3 to 6 months follow-up assessments). RESULTS Forty-six patients with a median age of 13.0 (3.5-15.5) years were included. About half of the patients (n = 24, 52.2%) had an identifiable risk factor for the development of AKI. Thirteen patients (28.3%) were anuric, and all of those were categorized as AKI KDIGO stage 3 (p < 0.001). Almost one quarter (n = 10, 21.7%) of patients required renal replacement therapy. Approximately 60% of patients (n = 26) had at least one sequelae, with proteinuria being the most common (n = 15, 38.5%; median (P25-75) urinary protein-to-creatinine ratio 0.30 (0.27-0.44) mg/mg), followed by reduced glomerular filtration rate (GFR) (n = 11, 27.5%; median (P25-75) GFR 75 (62-83) mL/min/1.73 m2). CONCLUSIONS Pediatric AKI is associated with substantial morbidity, with potential for proteinuria development and renal function impairment and a relevant impact on long-term prognosis.
Collapse
Affiliation(s)
- Carolina Silva Figueiredo
- Hospital do Divino Espírito Santo de Ponta Delgada, Serviço de Pediatria, Ilha de São Miguel, Portugal
| | | | - Liane Maria Correia Rodrigues da Costa Nogueira Silva
- Universidade do Porto, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal
- Centro Hospitalar Universitário de Santo António, Centro Materno-Infantil do Norte, Unidade de Nefrologia Pediátrica, Porto, Portugal
- Universidade do Porto, Instituto de Saúde Pública (EPIUnit), Porto, Portugal
- Universidade do Porto, Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal
| | - Maria do Sameiro Pinto César de Faria
- Centro Hospitalar Universitário de Santo António, Centro Materno-Infantil do Norte, Unidade de Nefrologia Pediátrica, Porto, Portugal
- Universidade do Porto e Universidade NOVA de Lisboa, Unidade de Ciências Biomoleculares Aplicadas (UCIBIO), Lisboa, Portugal
| | | | | |
Collapse
|
2
|
Slagle C, Askenazi D, Starr M. Recent Advances in Kidney Replacement Therapy in Infants: A Review. Am J Kidney Dis 2024; 83:519-530. [PMID: 38147895 DOI: 10.1053/j.ajkd.2023.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Revised: 10/10/2023] [Accepted: 10/14/2023] [Indexed: 12/28/2023]
Abstract
Kidney replacement therapy (KRT) is used to treat children and adults with acute kidney injury (AKI), fluid overload, kidney failure, inborn errors of metabolism, and severe electrolyte abnormalities. Peritoneal dialysis and extracorporeal hemodialysis/filtration can be performed for different durations (intermittent, prolonged intermittent, and continuous) through either adaptation of adult devices or use of infant-specific devices. Each of these modalities have advantages and disadvantages, and often multiple modalities are used depending on the scenario and patient-specific needs. Traditionally, these therapies have been challenging to deliver in infants due the lack of infant-specific devices, small patient size, required extracorporeal volumes, and the risk of hemodynamic stability during the initiation of KRT. In this review, we discuss challenges, recent advancements, and optimal approaches to provide KRT in hospitalized infants, including a discussion of peritoneal dialysis and extracorporeal therapies. We discuss each specific KRT modality, review newer infant-specific devices, and highlight the benefits and limitations of each modality. We also discuss the ethical implications for the care of infants who need KRT and areas for future research.
Collapse
Affiliation(s)
- Cara Slagle
- Division of Neonatology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana
| | - David Askenazi
- Division of Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama
| | - Michelle Starr
- Division of Nephrology and Division of Child Health Service Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
| |
Collapse
|
3
|
Sethi SK, Raina R, Sawan A, Asim S, Khant AK, Matnani M, Ganesan K, Lohia S, Sinha R, Rumana J, Haque SS, Kalra S, Safdar R, Prasad G, Ijaz I, Ashruf OS, Nair A, S S, Soni K, Shrestha D, Yadav S, Abeyagunawardena A, Luyckx VA, Alhasan KA, Sultana A. Assessment of South Asian Pediatric Acute Kidney Injury: Epidemiology and Risk Factors (ASPIRE)-a prospective study on "severe dialysis dependent pediatric AKI". Pediatr Nephrol 2024:10.1007/s00467-024-06324-6. [PMID: 38456915 DOI: 10.1007/s00467-024-06324-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 02/03/2024] [Accepted: 02/13/2024] [Indexed: 03/09/2024]
Abstract
BACKGROUND Pediatric acute kidney injury (AKI) is a global health concern with an associated mortality risk disproportionately pronounced in resource-limited settings. There is a pertinent need to understand the epidemiology of pediatric AKI in vulnerable populations. Here, we proposed a prospective study to investigate the epidemiology and associated risk factors of "severe dialysis dependent AKI" in children among South Asian nations which would be the first and largest of its kind. METHODS The ASPIRE study (part of PCRRT-ICONIC Foundation initiative) is a multi-center, prospective observational study conducted in South Asian countries. All children and adolescents ≤ 18 years of age who required dialysis for AKI in any of the collaborating medical centers were enrolled. Data collection was performed until one of the following endpoints was observed: (1) discharge, (2) death, and (3) discharge against medical advice. RESULTS From 2019 to 2022, a total of 308 children with severe AKI were enrolled. The mean age was 6.17 years (63% males). Secondary AKI was more prevalent than primary AKI (67.2%), which predominantly occurred due to infections, dehydration, and nephrotoxins. Common causes of primary AKI were glomerulonephritis, hemolytic uremic syndrome, lupus nephritis, and obstructive uropathy. Shock, need for ventilation, and coagulopathy were commonly seen in children with severe AKI who needed dialysis. The foremost kidney replacement therapy used was peritoneal dialysis (60.7%). The mortality rate was 32.1%. CONCLUSIONS Common causes of AKI in children in South Asia are preventable. Mortality is high among these children suffering from "severe dialysis dependent AKI." Targeted interventions to prevent and identify AKI early and initiate supportive care in less-resourced nations are needed.
Collapse
Affiliation(s)
- Sidharth Kumar Sethi
- Department of Pediatric Nephrology and Pediatric Kidney Transplantation, Kidney and Urology Institute, Medanta, The Medicity Hospital, Gurgaon, India.
| | - Rupesh Raina
- Department of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA
- Department of Nephrology, Akron Children's Hospital, Akron, OH, USA
| | - Ahmad Sawan
- Department of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA
| | - Sadaf Asim
- National Institute of Child Health, Karachi, Pakistan
| | | | - Manoj Matnani
- Department of Pediatrics, Dr. D.Y Patil Medical College and Hospital, Pune, Maharashtra, India
| | | | - Shraddha Lohia
- Bharati Vidyapeeth Deemed University, Pune, Maharashtra, India
| | - Rajiv Sinha
- Division of Paediatric Nephrology, Institute of Child Health, Kolkata, West Bengal, India
| | | | - Syed Saimul Haque
- Bangabandhu Sheikh Mujib Medical University Hospital, Dhaka, Bangladesh
| | - Suprita Kalra
- Army Hospital Research and Referral, New Delhi, India
| | - Rabia Safdar
- Department of Pediatric Nephrology, Nishtar Medical University, Multan, Pakistan
| | - Gopal Prasad
- Department of Nephrology, Patna Medical College and Hospital, Patna, India
| | - Iftikhar Ijaz
- Children Kidney Center, Department of Pediatrics, King Edward Medical University, Lahore, Pakistan
| | - Omer S Ashruf
- Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, USA
| | - Aishwarya Nair
- Department of Pediatric Nephrology and Pediatric Kidney Transplantation, Kidney and Urology Institute, Medanta, The Medicity Hospital, Gurgaon, India
| | - Savita S
- Department of Pediatric Nephrology and Pediatric Kidney Transplantation, Kidney and Urology Institute, Medanta, The Medicity Hospital, Gurgaon, India
| | - Kritika Soni
- Department of Pediatric Nephrology and Pediatric Kidney Transplantation, Kidney and Urology Institute, Medanta, The Medicity Hospital, Gurgaon, India
| | | | | | - Asiri Abeyagunawardena
- Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka
| | - Valerie A Luyckx
- Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland
- Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Department of Paediatric and Child Health, University of Cape Town, Cape Town, South Africa
| | - Khalid A Alhasan
- Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - Azmeri Sultana
- Dr. MR Khan Children's Hospital and Institute of Child Health, Dhaka, Bangladesh
| |
Collapse
|
4
|
Cortina G, Daverio M, Demirkol D, Chanchlani R, Deep A. Continuous renal replacement therapy in neonates and children: what does the pediatrician need to know? An overview from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Eur J Pediatr 2024; 183:529-541. [PMID: 37975941 PMCID: PMC10912166 DOI: 10.1007/s00431-023-05318-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 10/13/2023] [Accepted: 10/28/2023] [Indexed: 11/19/2023]
Abstract
Continuous renal replacement therapy (CRRT) is the preferred method for renal support in critically ill and hemodynamically unstable children in the pediatric intensive care unit (PICU) as it allows for gentle removal of fluids and solutes. The most frequent indications for CRRT include acute kidney injury (AKI) and fluid overload (FO) as well as non-renal indications such as removal of toxic metabolites in acute liver failure, inborn errors of metabolism, and intoxications and removal of inflammatory mediators in sepsis. AKI and/or FO are common in critically ill children and their presence is associated with worse outcomes. Therefore, early recognition of AKI and FO is important and timely transfer of patients who might require CRRT to a center with institutional expertise should be considered. Although CRRT has been increasingly used in the critical care setting, due to the lack of standardized recommendations, wide practice variations exist regarding the main aspects of CRRT application in critically ill children. Conclusion: In this review, from the Critical Care Nephrology section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC), we summarize the key aspects of CRRT delivery and highlight the importance of adequate follow up among AKI survivors which might be of relevance for the general pediatric community. What is Known: • CRRT is the preferred method of renal support in critically ill and hemodynamically unstable children in the PICU as it allows for gentle removal of fluids and solutes. • Although CRRT has become an important and integral part of modern pediatric critical care, wide practice variations exist in all aspects of CRRT. What is New: • Given the lack of literature on guidance for a general pediatrician on when to refer a child for CRRT, we recommend timely transfer to a center with institutional expertise in CRRT, as both worsening AKI and FO have been associated with increased mortality. • Adequate follow-up of PICU patients with AKI and CRRT is highlighted as recent findings demonstrate that these children are at increased risk for adverse long-term outcomes.
Collapse
Affiliation(s)
- Gerard Cortina
- Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria
| | - Marco Daverio
- Pediatric Intensive Care Unit, University Hospital of Padua, Padua, Italy
| | - Demet Demirkol
- Pediatric Intensive Care Unit, Faculty of Medicine, Istanbul University, Istanbul, Turkey
| | - Rahul Chanchlani
- Division of Pediatric Nephrology, Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, ON, Canada
| | - Akash Deep
- Pediatric Intensive Care Unit, Kings College London, London, UK.
| |
Collapse
|
5
|
Vo LT, Do VC, Trinh TH, Vu T, Nguyen TT. Combined Therapeutic Plasma Exchange and Continuous Renal Replacement Therapy in Children With Dengue-Associated Acute Liver Failure and Shock Syndrome: Single-Center Cohort From Vietnam. Pediatr Crit Care Med 2023; 24:818-828. [PMID: 37310173 PMCID: PMC10540756 DOI: 10.1097/pcc.0000000000003304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVES Pediatric acute liver failure (PALF) is a fatal complication in patients with severe dengue. To date, clinical data on the combination of therapeutic plasma exchange (TPE) and continuous renal replacement therapy (CRRT) for managing dengue-associated PALF concomitant with shock syndrome are limited. DESIGN Retrospective cohort study (January 2013 to June 2022). PATIENTS Thirty-four children. SETTING PICU of tertiary Children's Hospital No. 2 in Vietnam. INTERVENTIONS We assessed a before-versus-after practice change at our center of using combined TPE and CRRT (2018 to 2022) versus CRRT alone (2013 to 2017) in managing children with dengue-associated acute liver failure and shock syndrome. Clinical and laboratory data were reviewed from PICU admission, before and 24 h after CRRT and TPE treatments. The main study outcomes were 28-day in-hospital mortality, hemodynamics, clinical hepatoencephalopathy, and liver function normalization. MEASUREMENTS AND MAIN RESULTS A total of 34 children with a median age of 10 years (interquartile range: 7-11 yr) underwent standard-volume TPE and/or CRRT treatments. Combined TPE and CRRT ( n = 19), versus CRRT alone ( n = 15), was associated with lower proportion of mortality 7 of 19 (37%) versus 13 of 15 (87%), difference 50% (95% CI, 22-78; p < 0.01). Use of combined TPE and CRRT was associated with substantial advancements in clinical hepatoencephalopathy, liver transaminases, coagulation profiles, and blood lactate and ammonia levels (all p values < 0.001). CONCLUSIONS In our experience of children with dengue-associated PALF and shock syndrome, combined use of TPE and CRRT, versus CRRT alone, is associated with better outcomes. Such combination intervention was associated with normalization of liver function, neurological status, and biochemistry. In our center we continue to use combined TPE and CRRT rather than CRRT alone.
Collapse
Affiliation(s)
- Luan Thanh Vo
- Infectious Disease Department, Children Hospital 2, Ho Chi Minh City, Vietnam
| | - Viet Chau Do
- Infectious Disease Department, Children Hospital 2, Ho Chi Minh City, Vietnam
| | - Tung Huu Trinh
- Infectious Disease Department, Children Hospital 2, Ho Chi Minh City, Vietnam
| | - Thien Vu
- NCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan
- AI Nutrition Project, National Institutes of Biomedical Innovation, Health and Nutrition, (NIBIOHN), Ibaraki, Osaka, Japan
| | - Thanh Tat Nguyen
- Infectious Disease Department, Children Hospital 2, Ho Chi Minh City, Vietnam
- Woolcock Institute of Medical Research, Ho Chi Minh City, Vietnam
| |
Collapse
|
6
|
Gerçel G, Anadolulu Aİ. Acute peritoneal dialysis in the newborn: A safe and feasible method. J Pediatr Surg 2023; 58:453-457. [PMID: 36150931 DOI: 10.1016/j.jpedsurg.2022.08.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Revised: 08/16/2022] [Accepted: 08/24/2022] [Indexed: 10/15/2022]
Abstract
INTRODUCTION We aimed to evaluate the patient characteristics of neonates treated with peritoneal dialysis (PD) and review our experience with placement of PD catheters. METHODS Records of neonates treated with PD between January 2019 and January 2022 were retrospectively analyzed. RESULTS Swan neck curl PD catheters with double cuffs were used in 85 neonates as a bedside procedure with one cuff remaining within the abdomen. There were 44 (51.7%) males and 41 (48.3%) females. Their mean gestational age was 33.6 ± 4.9 (22-40) weeks and the mean birth weight was 2315,5 ± 1039 (500-4700) g. The primary diagnoses were asphyxia (n = 22, 25.9%), prematurity (n = 21, 24.7%), inborn errors of metabolism (n = 11, 12.9%), sepsis (n = 7, 8.2%), necrotizing enterocolitis (n = 5, 5.9%), dehydration (n = 5, 5.9%), hydrops fetalis (n = 5, 5.9%), congenital heart diseases (n = 5, 5.9%) and renal anomalies (n = 4, 4.7%). The mean duration of PD was 11.6 ± 13.7 days (range 1 to 75 days). Catheter-related complications occurred in 7 (8.2%) patients. These were drainage problems (n = 4), leakage (n = 1), incisional hernia (n = 1) and wound dehiscence (n = 1). Mortality because of underlying condition occurred in 57 (67.1%) patients. Mean pre-dialysis pH and sodium levels were statistically higher in surviving newborns than in those with a fatal outcome (7.19 vs 7.09 and 144.4 mmol/L vs 134.6 mmol/L, respectively) (p<0.05). CONCLUSIONS PD is a safe, simple and effective therapy in neonates. The mortality rate in those treated with PD is high, especially due to serious underlying diseases. Lack of appropriate devices necessitates revisions in the catheters and techniques used for PD treatment. TYPE OF STUDY Case series LEVEL OF EVIDENCE: IV.
Collapse
Affiliation(s)
- Gonca Gerçel
- Department of Pediatric Surgery, Şanlıurfa Training and Research Hospital, Şanlıurfa, Turkey.
| | - Ali İhsan Anadolulu
- Department of Pediatric Surgery, Mehmet Akif İnan Training and Research Hospital, Şanlıurfa, Turkey
| |
Collapse
|
7
|
Güngör T, Kargın Çakıcı E, Yazılıtaş F, Karakaya D, Çelikkaya E, Bülbül M. Acute intermittent hemodialysis management in childhood: A single center experience. Ther Apher Dial 2023; 27:66-72. [PMID: 35434923 DOI: 10.1111/1744-9987.13854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 02/27/2022] [Accepted: 04/15/2022] [Indexed: 01/05/2023]
Abstract
INTRODUCTION The objective of this study was to determine the common indications of acute intermittent hemodialysis (IHD) treatment in childhood and to assess the characteristics of the procedure, complications, and prognosis. METHODS The study included 102 patients aged between 0 and 18 years, who had been acute dialysis indication and treated with IHD. RESULTS In terms of acute kidney injury (AKI) etiology, glomerular diseases were prominent in 56% of the patients, and 8.6% of surviving patients progressed to end-stage renal disease. Regarding the cause of AKI, having the glomerular disease was determined to be directly associated (p = 0.01) with the risk of progression to chronic kidney disease (CKD) regardless of age, gender, onset time of renal replacement therapy. CONCLUSION Glomerular diseases were the most common in AKI etiology and were associated with the progression to CKD, independent of age, gender and the time of IHD onset in our study.
Collapse
Affiliation(s)
- Tülin Güngör
- Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Evrim Kargın Çakıcı
- Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Fatma Yazılıtaş
- Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Deniz Karakaya
- Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Evra Çelikkaya
- Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey
| | - Mehmet Bülbül
- Department of Pediatric Nephrology, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
8
|
Liu Y, Thaker H, Wang C, Xu Z, Dong M. Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome. Toxins (Basel) 2022; 15:10. [PMID: 36668830 PMCID: PMC9862836 DOI: 10.3390/toxins15010010] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 12/13/2022] [Accepted: 12/17/2022] [Indexed: 12/24/2022] Open
Abstract
Shiga toxin-producing Escherichia coli (STEC)-associated hemolytic uremic syndrome (STEC-HUS) is a clinical syndrome involving hemolytic anemia (with fragmented red blood cells), low levels of platelets in the blood (thrombocytopenia), and acute kidney injury (AKI). It is the major infectious cause of AKI in children. In severe cases, neurological complications and even death may occur. Treating STEC-HUS is challenging, as patients often already have organ injuries when they seek medical treatment. Early diagnosis is of great significance for improving prognosis and reducing mortality and sequelae. In this review, we first briefly summarize the diagnostics for STEC-HUS, including history taking, clinical manifestations, fecal and serological detection methods for STEC, and complement activation monitoring. We also summarize preventive and therapeutic strategies for STEC-HUS, such as vaccines, volume expansion, renal replacement therapy (RRT), antibiotics, plasma exchange, antibodies and inhibitors that interfere with receptor binding, and the intracellular trafficking of the Shiga toxin.
Collapse
Affiliation(s)
- Yang Liu
- Department of Nephrology, The First Hospital of Jilin University, Changchun 130021, China
- Department of Urology, Boston Children’s Hospital, Boston, MA 02115, USA
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA
- Department of Surgery, Harvard Medical School, Boston, MA 02115, USA
| | - Hatim Thaker
- Department of Urology, Boston Children’s Hospital, Boston, MA 02115, USA
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA
- Department of Surgery, Harvard Medical School, Boston, MA 02115, USA
| | - Chunyan Wang
- Department of Nephrology, Children’s Hospital of Fudan University, Shanghai 201102, China
| | - Zhonggao Xu
- Department of Nephrology, The First Hospital of Jilin University, Changchun 130021, China
| | - Min Dong
- Department of Urology, Boston Children’s Hospital, Boston, MA 02115, USA
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA
- Department of Surgery, Harvard Medical School, Boston, MA 02115, USA
| |
Collapse
|
9
|
Zama D, Mondardini MC, Petris MG, Amigoni A, Carraro F, Zanaroli A, dell'Orso G, Faraci M, Spaggiari S, Muggeo P, Perruccio K, Mura R, Barone A, Muratore E, Cesaro S. Pediatric cancer and hematopoietic stem cell transplantation patients requiring renal replacement therapy: results of the retrospective nationwide AIEOP study. Leuk Lymphoma 2022; 63:2923-2930. [PMID: 35819873 DOI: 10.1080/10428194.2022.2095628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
In children affected by malignancies and/or who received hematopoietic stem cell transplantation (HSCT), acute kidney injury (AKI) may occur causing a high mortality rate, despite the implementation of renal replacement therapy (RRT). We performed a nationwide, multicenter, retrospective, observational cohort study including consecutive patients between January 2010 and December 2019. One hundred and fourteen episodes of AKI requiring RRT coming from nine different Italian centers were included. The overall mortality rate was 61.4%. At the 3-month follow-up, the mortality rate was 47.4%. The mortality rate was higher in transplanted patients than those receiving chemotherapy. In particular, HSCT (p = 0.048) and invasive mechanical ventilation (p = 0.040) were significantly associated with death at three months after the end of dialysis in the multivariate analysis. Pediatric patients affected by malignancies complicated by AKI requiring RRT have a high mortality. The main factors associated to death are respiratory failure and having received HSCT.
Collapse
Affiliation(s)
- Daniele Zama
- Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | | | - Maria Grazia Petris
- Women's and Children's Health, Clinic of Pediatric Hemato-Oncology, University of Padua, Padua, Italy
| | - Angela Amigoni
- Pediatric Intensive Care Unit, Woman and Child's Health Department, University Hospital of Padova, Padova, Italy
| | - Francesca Carraro
- Pediatric Hematology and Oncology Department, Stem Cell Transplantation and Cell Therapy Division, "Regina Margherita" Pediatric Hospital, Torino, Italy
| | - Andrea Zanaroli
- Residency School in Pediatrics, University of Bologna, Bologna, Italy
| | - Gianluca dell'Orso
- Pediatric Hemato-oncology Department, Hematopoietic Stem Cell Transplantation Unit, IRCSS G. Gaslini, Genova, Italy
| | - Maura Faraci
- Pediatric Hemato-oncology Department, Hematopoietic Stem Cell Transplantation Unit, IRCSS G. Gaslini, Genova, Italy
| | - Stefania Spaggiari
- Pediatric Hematology and Oncology, Mother and Child's Health Department, University Hospital of Verona, Verona, Italy
| | - Paola Muggeo
- Pediatric Hematology and Oncology Department, University of Bari, Bari, Italy
| | - Katia Perruccio
- Pediatric Hematology and Oncology Department, "Santa Maria della Misericordia" Hospital, Perugia, Italy
| | - Rosamaria Mura
- Pediatric Hematology and Oncology Department, "A Cao" Microcitemic Pediatric Hospital, "Botzu" Medical Center, Cagliari, Italy
| | - Angelica Barone
- Pediatric Oncohematology Unit, University Hospital of Parma, Parma, Italy
| | - Edoardo Muratore
- Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Simone Cesaro
- Pediatric Hematology and Oncology, Mother and Child's Health Department, University Hospital of Verona, Verona, Italy
| |
Collapse
|
10
|
Thanh NT, Dat NT, Thinh TN, Phuong NTM, Thanh MTH, Bao NT, Son PT, Viet DC, Tung TH, Thien V, Luan VT. Therapeutic plasma exchange and continuous renal replacement therapy in pediatric dengue-associated acute liver failure: A case series from Vietnam. Transfus Apher Sci 2022; 62:103617. [PMID: 36522271 DOI: 10.1016/j.transci.2022.103617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Revised: 11/04/2022] [Accepted: 11/23/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND OBJECTIVES Paediatric dengue-associated acute liver failure (PALF) is a rare and fatal complication. To date, clinical data regarding the combination of therapeutic plasma exchange (TPE) and continuous renal replacement therapy (CRRT) for the treatment of dengue-associated PALF are limited. METHODS We conducted a single-center, retrospective study of all children with dengue-associated PALF admitted to the paediatric intensive care unit of Children Hospital No.2, Vietnam, who were treated with TPE+CRRT between January 2021 and March 2022. The main study outcomes were in-hospital survival, normalisation of hepatic function, and hepatic encephalopathy improvement. RESULTS Twelve patients aged from 06 to 12 years underwent TPE+CRRT procedures. Among them, three (25 %) patients died of severe sepsis and septic shock confirmed by Enterobacteriaceae spp. haemocultures (stable on maintenance treatment of COVID-19-associated MIS-C with low dose of oral steroids on hospital admission), acute respiratory distress syndrome (ARDS), and clinically apparent intracranial haemorrhage. Nine patients (75 %) survived. The paediatric mortality risk score improved significantly at discharge compared with PICU admission (P < 0.01). Markedly, all twelve patients were diagnosed with hepatoencephalopathy of grades III and IV on PICU admission. After the combined TPE+CRRT interventions, there were substantial improvements in liver transaminases levels, coagulation profiles, and metabolic biomarkers. Normal neurological functions were observed in nine alive patients at hospital discharge. Only one patient experienced an adverse event of slightly low blood pressure, which rapidly self-resolved. INTERPRETATION AND CONCLUSIONS Combined TPE+CRRT significantly improved survival outcome, neurological status, and rapid normalisation of liver functions in dengue-associated PALF.
Collapse
Affiliation(s)
- Nguyen Tat Thanh
- Children Hospital 2, Ho Chi Minh City, Viet Nam; Woolcock Institute of Medical Research, Viet Nam
| | - Nguyen Tat Dat
- University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam
| | | | - Ngo Thi Mai Phuong
- Children Hospital 2, Ho Chi Minh City, Viet Nam; University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam.
| | | | | | | | - Do Chau Viet
- Children Hospital 2, Ho Chi Minh City, Viet Nam.
| | | | - Vu Thien
- Shiga University of Medical Science, Otsu City, Shiga, Japan.
| | | |
Collapse
|
11
|
Mohamed TH, Morgan J, Mottes TA, Askenazi D, Jetton JG, Menon S. Kidney support for babies: building a comprehensive and integrated neonatal kidney support therapy program. Pediatr Nephrol 2022:10.1007/s00467-022-05768-y. [PMID: 36227440 DOI: 10.1007/s00467-022-05768-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Revised: 08/01/2022] [Accepted: 09/08/2022] [Indexed: 11/26/2022]
Abstract
Kidney support therapy (KST), previously referred to as Renal Replacement Therapy, is utilized to treat children and adults with severe acute kidney injury (AKI), fluid overload, inborn errors of metabolism, and kidney failure. Several forms of KST are available including peritoneal dialysis (PD), intermittent hemodialysis (iHD), and continuous kidney support therapy (CKST). Traditionally, extracorporeal KST (CKST and iHD) in neonates has had unique challenges related to small patient size, lack of neonatal-specific devices, and risk of hemodynamic instability due to large extracorporeal circuit volume relative to patient total blood volume. Thus, PD has been the most commonly used modality in infants, followed by CKST and iHD. In recent years, CKST machines designed for small children and novel filters with smaller extracorporeal circuit volumes have emerged and are being used in many centers to provide neonatal KST for toxin removal and to achieve fluid and electrolyte homeostasis, increasing the options available for this unique and vulnerable group. These new treatment options create a dramatic paradigm shift with recalibration of the benefit: risk equation. Renewed focus on the infrastructure required to deliver neonatal KST safely and effectively is essential, especially in programs/units that do not traditionally provide KST to neonates. Building and implementing a neonatal KST program requires an expert multidisciplinary team with strong institutional support. In this review, we first describe the available neonatal KST modalities including newer neonatal and infant-specific platforms. Then, we describe the steps needed to develop and sustain a neonatal KST team, including recommendations for provider and nursing staff training. Finally, we describe how quality improvement initiatives can be integrated into programs.
Collapse
Affiliation(s)
- Tahagod H Mohamed
- Division of Nephrology and Hypertension, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH, USA.
- The Kidney and Urinary Tract Center, Nationwide Children's Hospital, 700 Children's Dr, Columbus, OH, 430205, USA.
| | - Jolyn Morgan
- The Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
| | - Theresa A Mottes
- Division of Nephrology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | - David Askenazi
- Pediatric and Infant Center for Acute Nephrology, Division of Pediatric Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Jennifer G Jetton
- Section of Nephrology, Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, WI, USA
| | - Shina Menon
- Division of Pediatric Nephrology, Department of Pediatrics, Seattle Children's Hospital and University of Washington, Seattle, WA, USA
| |
Collapse
|
12
|
Duyu M, Turkozkan C. Clinical features and risk factors associated with mortality in critically ill children requiring continuous renal replacement therapy. Ther Apher Dial 2022; 26:1121-1130. [PMID: 35129292 DOI: 10.1111/1744-9987.13811] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 12/07/2021] [Accepted: 02/05/2022] [Indexed: 11/27/2022]
Abstract
INTRODUCTION The aims of this study were to describe the demographic characteristics of critically ill children requiring continuous renal replacement therapy (CRRT) at our pediatric intensive care unit (PICU) and to explore risk factors associated with mortality. METHODS A retrospective cohort of 121 critically ill children who received CRRT from May 2015 to May 2020 in the PICU of a tertiary healthcare institution was evaluated. RESULTS Overall mortality was 29.8%. In patients diagnosed with sepsis, time until CRRT initiation was significantly shorter in survivors compared to non-survivors (p = 0.036). Based on multivariate logistic regression, presence of comorbidity (OR: 5.71), diagnoses of pneumonia/respiratory failure at admission (OR:16.16), and high lactate level at CRRT initiation (OR:1.43) were independently associated with mortality. CONCLUSION In the context of the population studied, mortality rate was lower than previously reported. Despite having a large series, heterogenous characteristics and limitations in subgroups may have influenced results and survival. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Muhterem Duyu
- Department of Pediatrics, Pediatric Intensive Care Unit, Istanbul Medeniyet University Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey
| | - Ceren Turkozkan
- Department of Pediatrics, Istanbul Medeniyet University Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey
| |
Collapse
|
13
|
Guzzo I, de Galasso L, Bayazit AK, Yildizdas D, Schmitt CP, Hayes W, Shroff R, Jankauskiene A, Virsilas E, Longo G, Vidal E, Mir S, Bulut IK, Tkaczyk M, Mencarelli F, Bertulli C, Cvetkovic M, Kostic M, Paglialonga F, Montini G, Yilmaz E, Teixeira A, Atmis B, Schaefer F. Acute pediatric kidney replacement therapies in Europe: demographic results from the EurAKId Registry. Nephrol Dial Transplant 2021; 37:770-780. [PMID: 34586417 DOI: 10.1093/ndt/gfab280] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2021] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Acute kidney injury (AKI), particularly that requiring dialysis, is a severe complication in hospitalized children associated with high morbidity and mortality. A prospective European AKI registry (EurAKId registry, NCT02960867) was created to describe the epidemiology and outcomes of pediatric patients treated with acute dialysis. METHODS Children were recruited who were between 0 and 18 years of age and were treated both in and outside the Pediatric Intensive Care Unit (PICU) with peritoneal dialysis (PD), hemodialysis (HD) or continuous kidney replacement therapy (CKRT) for AKI or metabolic derangement, fluid overload (FO), sepsis, or respiratory distress. Five age groups and 12 categories of primary diseases were defined. RESULTS Data on 340 patients were analyzed, of whom 86% received dialysis for AKI and 14% for reasons other than AKI. Boys accounted for 60% of the patients. Illness severity was greater in children with cardiac and hematologic diseases than those with kidney diseases. Most patients received dialysis in the PICU (84%). The most frequently used dialysis modality was CKRT (64%), followed by PD (14%) and HD (14%). The overall survival rate was 65%. Survival was significantly lower in children with three comorbidities than in children with no comorbidities (41% and 83%, p < 0.001). CONCLUSIONS The EurAKId registry is the first prospective registry considering pediatric acute kidney replacement therapies (KRT) in both critical and non-critical care settings, focusing on the three dialysis modalities in Europe. The clinical indications for KRT have expanded; our population was characterized by critically ill patients, primarily boys, who frequently received dialysis in the PICU with CKRT.
Collapse
Affiliation(s)
- Isabella Guzzo
- Division of Nephrology and Dialysis, Department of Pediatrics, Bambino Gesù Children's Hospital and Research Institute, Piazza S. Onofrio 4, 00165, Rome, Italy
| | - Lara de Galasso
- Division of Nephrology and Dialysis, Department of Pediatrics, Bambino Gesù Children's Hospital and Research Institute, Piazza S. Onofrio 4, 00165, Rome, Italy
| | - Aysun Karabay Bayazit
- Department of Pediatric Nephrology, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Dincer Yildizdas
- Department of Pediatric Nephrology, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Claus Peter Schmitt
- Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany
| | - Wesley Hayes
- Department of Pediatric Nephrology, UCL Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - Rukshana Shroff
- Department of Pediatric Nephrology, UCL Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - Augustina Jankauskiene
- Clinic of Pediatrics, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
| | - Ernestas Virsilas
- Clinic of Pediatrics, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
| | - Germana Longo
- Pediatric Nephrology, Azienda Ospedaliera-University of Padua, Padua, Italy
| | - Enrico Vidal
- Pediatric Nephrology, Azienda Ospedaliera-University of Padua, Padua, Italy
| | - Sevgi Mir
- Department of Pediatric Nephrology, Ege University Faculty of Medicine, Izmir, Turkey
| | - Ipek Kaplan Bulut
- Department of Pediatric Nephrology, Ege University Faculty of Medicine, Izmir, Turkey
| | - Marcin Tkaczyk
- Department of Pediatrics and Immunology, Nephrology Division, Polish Mothers Memorial Hospital Research Institute, Lodz, Poland
| | - Francesca Mencarelli
- Nephrology and Dialysis Unit, Department of Pediatrics, S Orsola-Malpighi Hospital, Scientific Institute for Research and Healthcare (IRCCS), Bologna, Italy
| | - Cristina Bertulli
- Nephrology and Dialysis Unit, Department of Pediatrics, S Orsola-Malpighi Hospital, Scientific Institute for Research and Healthcare (IRCCS), Bologna, Italy
| | - Mrjana Cvetkovic
- Department of Nephrology, University Children Hospital, Belgrade, Serbia
| | - Mirjana Kostic
- Department of Nephrology, University Children Hospital, Belgrade, Serbia
| | - Fabio Paglialonga
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione Ca' Grande IRRCS Ospedale Maggiore Policlinico, Milan, Italy
| | - Giovanni Montini
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione Ca' Grande IRRCS Ospedale Maggiore Policlinico, Milan, Italy
| | - Ebru Yilmaz
- Pediatric Nephrology, Dr Behcet Children Research and Education Hospital, Izmir, Turkey
| | - Ana Teixeira
- Pediatric Nephrology, Centro Materno-Infantil do Norte, Porto, Portugal
| | - Bahriye Atmis
- Erzurum Regional Training and Research Hospital, Erzurum, Turkey
| | - Franz Schaefer
- Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany
| | | |
Collapse
|
14
|
Wu NL, Hingorani S. Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients. Pediatr Nephrol 2021; 36:2675-2686. [PMID: 33411070 PMCID: PMC11198913 DOI: 10.1007/s00467-020-04842-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Revised: 09/10/2020] [Accepted: 10/22/2020] [Indexed: 01/26/2023]
Abstract
Pediatric oncology and hematopoietic cell transplant (HCT) patients are susceptible to both acute kidney injury (AKI) and chronic kidney disease (CKD). The etiologies of AKI vary but include tumor infiltration, radiation, drug-induced toxicity, and fluid and electrolyte abnormalities including tumor lysis syndrome. HCT patients can also have additional complications such as sinusoidal obstructive syndrome, graft-versus-host disease, or thrombotic microangiopathy. For patients with severe AKI requiring dialysis, multiple modalities can be used successfully, although continuous kidney replacement therapy (CKRT) is often the principal modality for critically ill patients. While increasing numbers of pediatric cancer and HCT patients are now surviving long term, they remain at risk for a number of chronic medical conditions, including CKD. Certain high-risk patients, due to underlying risk factors or treatment-related complications, eventually develop kidney failure and may require kidney replacement therapies. Management of co-morbidities and complications associated with kidney failure, including use of erythropoietin for anemia and potential need for ongoing cancer-related treatment while on dialysis, is an additional consideration in this patient population. Kidney transplantation can be successfully performed in pediatric cancer survivors, although additional features such as specific cancer diagnosis and duration of remission should be considered.
Collapse
Affiliation(s)
- Natalie L Wu
- Department of Pediatrics, Division of Hematology/Oncology, Fred Hutchinson Cancer Research Center, Seattle Children's Hospital, University of Washington School of Medicine, 4800 Sand Point Way NE, Seattle, WA, 98105, USA
| | - Sangeeta Hingorani
- Department of Pediatrics, Division of Nephrology, Fred Hutchinson Cancer Research Center, Seattle Children's Hospital, University of Washington School of Medicine, 4800 Sand Point Way NE, Seattle, WA, 98105, USA.
| |
Collapse
|
15
|
Hemodynamic disturbances and oliguria during continuous kidney replacement therapy in critically ill children. Pediatr Nephrol 2021; 36:1889-1899. [PMID: 33433709 DOI: 10.1007/s00467-020-04804-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 08/15/2020] [Accepted: 09/29/2020] [Indexed: 10/22/2022]
Abstract
BACKGROUND About 1.5% of patients admitted to the Pediatric Intensive Care Unit (PICU) will require continuous kidney replacement therapy (CKRT)/renal replacement therapy (CRRT). Mortality of these patients ranges from 30 to 60%. CKRT-related hypotension (CKRT-RHI) can occur in 19-45% of patients. Oliguria after onset of CKRT is also common, but to date has not been addressed directly in the scientific literature. METHODS A prospective observational study was conducted to define factors involved in the hemodynamic changes that take place during the first hours of CKRT, and their relationship with urinary output. RESULTS Twenty-five patients who were admitted to a single-center PICU requiring CKRT between January 1, 2014, and December 31, 2018, were included, of whom 56.3% developed CKRT-RHI. This drop in blood pressure was transient and rapidly restored to baseline, and significantly improved after the third hour of CKRT, as core temperature and heart rate decreased. Urine output significantly decreased after starting CKRT, and 72% of patients were oliguric after 6 h of therapy. Duration of CKRT was significantly longer in patients presenting with oliguria than in non-oliguric patients (28.7 vs. 7.9 days, p = 0.013). CONCLUSIONS The initiation of CKRT caused hemodynamic instability immediately after initial connection in most patients, but had a beneficial effect on the patient's hemodynamic status after 3 h of therapy, presumably owing to decreases in body temperature and heart rate. Urine output significantly decreased in all patients and was not related to negative fluid balance, patient's hemodynamic status, CKRT settings, or kidney function parameters.
Collapse
|
16
|
Tain YL, Kuo HC, Hsu CN. Changing trends in dialysis modalities utilization and mortality in children, adolescents and young adults with acute kidney injury, 2010-2017. Sci Rep 2021; 11:11887. [PMID: 34088938 PMCID: PMC8178371 DOI: 10.1038/s41598-021-91171-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Accepted: 05/07/2021] [Indexed: 11/09/2022] Open
Abstract
The aim of the study was to assess trends in the relative use of dialysis modalities in the hospital-based pediatric cohort and to determine risk factors associated with in-hospital morality among pediatric patients receiving dialysis for acute kidney injury (AKI). Patients aged < 20 years who received dialysis between 2010 and 2017 were identified from electronic health records databases of a Taiwan's healthcare delivery system. The annual uses of intermittent hemodialysis (HD), continuous and automated peritoneal dialysis (PD) and continuous kidney replacement therapy (CKRT) were assessed using Cochran-Armitage Tests for trend. Among patients who received their first dialysis as inpatients for AKI, a multivariate logistic regression model was employed to assess mortality risks associated with dialysis modalities, patient demographics, complexity of baseline chronic disease, and healthcare service use during their hospital stays. Kidney dialysis was performed 37.9 per patient per year over the study period. Intermittent hemodialysis (HD) (73.3%) was the most frequently used dialysis modality. In the inpatient setting, the relative annual use of CKRT increased over the study period, while HD use concomitantly declined (P < 0.0001). The overall in-hospital mortality rate after dialysis for AKI was 33.6%, which remained steady over time (P = 0.2411). Patients aged < 2 years [adjusted odds ratio: (aOR) 3.36; 95% confidence interval (CI) 1.34-8.93] and greater vasoactive regimen use (aOR: 17.1; 95% CI: 5.3-55.21) were significantly associated with dialysis-related mortality. Overall treatment modality used for dialysis in pediatric patients increased slowly in the study period, and HD and CRKT modality uses largely evolved in the inpatient setting. Younger ages and use of more vasoactive medication regimens were independently associated with increased early mortality in patients on AKI-dialysis.
Collapse
Affiliation(s)
- You-Lin Tain
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Kaohsiung, 833, Taiwan
| | - Hsiao-Ching Kuo
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan
| | - Chien-Ning Hsu
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan.
- School of Pharmacy, Kaohsiung Medical University, Kaohsiung, 807, Taiwan.
| |
Collapse
|
17
|
Chanchlani R, Young C, Farooq A, Sanger S, Sethi S, Chakraborty R, Tibrewal A, Raina R. Evolution and change in paradigm of hemodialysis in children: a systematic review. Pediatr Nephrol 2021; 36:1255-1271. [PMID: 33188608 DOI: 10.1007/s00467-020-04821-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2020] [Revised: 09/29/2020] [Accepted: 10/12/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND There are similarities in hemodialysis (HD) between adults and children and also unique pediatric aspects. In this systematic review, we evaluated the existing HD literature, including vascular access, indications, parameters, and outcomes as a reflection on real-life HD practices. METHODS Medline, Embase, CINAHL, Web of Science, and Cochrane Library were systematically searched for literature on HD in children (1-20 years). Two reviewers independently assessed the literature and data on indications; vascular access, outcomes, and specific parameters for HD were extracted. RESULTS Fifty-four studies (8751 patients) were included in this review. Studies were stratified into age groups 1-5, 6-12, and 13-20 years based on median/mean age reported in the study, as well as era of publication (1990-2000, 2001-2010, and 2011-2019). Across all age groups, both arteriovenous fistulas and central venous catheters were utilized for vascular access. Congenital abnormalities and glomerulopathy were the most common HD indications. HD parameters including HD session duration, dialysate and blood flow rates, urea reduction ratio, and ultrafiltration were characterized for each age group, as well as common complications including catheter dysfunction and intradialytic hypotension. Median mortality rates were 23.3% (3.3), 7.6% (14.5), and 2.0% (3.0) in ages 1-5, 6-12, and 13-20 years, respectively. Median transplantation rates were 41.6% (38.3), 52.0% (32.0), and 21% (25.6) in ages 1-5, 6-12, and 13-20, respectively. CONCLUSION This comprehensive systematic review summarizes available literature on HD in children and young adults, including best vascular access, indications, technical aspects, and outcomes, and reflects on HD practices over the last three decades.
Collapse
Affiliation(s)
- Rahul Chanchlani
- Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada.,Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada
| | - Claire Young
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Aisha Farooq
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Stephanie Sanger
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - Sidharth Sethi
- Pediatric Nephrology & Pediatric Kidney Transplantation, Kidney and Urology Institute, Medanta, The Medicity Hospital, Gurgaon, India
| | - Ronith Chakraborty
- Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA
| | | | - Rupesh Raina
- Akron Nephrology Associates/Cleveland Clinic Akron General, Akron, OH, USA. .,Department of Nephrology, Akron Children's Hospital, Akron, OH, USA.
| |
Collapse
|
18
|
Ambarsari CG, Cahyadi D, Sari L, Satria O, Sahli F, Darmadi TL, Kadaristiana A. Late diagnosis of Lesch-Nyhan disease complicated with end-stage renal disease and tophi burst: a case report. Ren Fail 2020; 42:113-121. [PMID: 31985336 PMCID: PMC7034128 DOI: 10.1080/0886022x.2020.1713805] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Background Lesch–Nyhan disease (LND) is a rare X-linked recessive inborn error of purine metabolism. Late diagnosis of LND may cause significant morbidity. LND cases have never been reported in Indonesia. Case report A 15-year-old male who had been diagnosed with cerebral palsy was referred to our hospital due to renal failure requiring emergency dialysis. The patient presented with three classic manifestations of LND: increased uric acid levels, neurological disorders, and self-injurious behaviors. LND was suspected because of an abscess-like lump on the left ankle that was confirmed to be a tophus, which had burst and discharged thick masses containing blood, debris, and white crystal materials. The diagnosis of LND was confirmed by the presence of a deletion to exon 1 of the HPRT1 gene. The patient received oral allopurinol daily and treatment for end-stage renal disease (ESRD), which included regular dialysis and subcutaneous administration of erythropoietin. At a 2-month follow-up, he improved clinically with a 71% decrease in uric acid levels after regular dialysis and allopurinol treatment. Conclusion In developed countries, LND can be diagnosed as early as 3 days after birth. However, diagnosis in the present case was delayed due to the rarity of the disease and the limited number of facilities in Indonesia that offer genetic counseling. Late diagnosis of LND leads to ESRD and irreversible abnormalities. This is the first case of LND presenting with a unique clinical presentation of tophus burst reported in Indonesia.
Collapse
Affiliation(s)
- Cahyani Gita Ambarsari
- Pediatric Nephrology Division, Department of Child Health, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Central Jakarta, Indonesia.,Pediatric Centre, Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia
| | - Daffodilone Cahyadi
- Orthopaedic Centre, Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia
| | - Lenny Sari
- Pathology Anatomy, Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia
| | - Oryza Satria
- Orthopaedic Centre, Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia.,Department of Orthopaedic and Traumatology, Fatmawati Hospital, South Jakarta, Indonesia
| | - Felly Sahli
- Radiology Centre, Pondok Indah Bintaro Jaya Hospital, South Tangerang, Indonesia
| | | | - Agustina Kadaristiana
- Pediatric Nephrology Division, Department of Child Health, Faculty of Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Central Jakarta, Indonesia
| |
Collapse
|
19
|
Abstract
Because of the lack of early recognition and referral, the incidence of pediatric acute kidney injury (AKI) in Asia still is underestimated. Although each diagnostic criteria has its own merits, the Kidney Disease Improving Global Outcomes classification now is widely accepted. In Asia, the spectrum of pediatric AKI is wide-ranging, from pediatric AKI in highly sophisticated tertiary-care pediatric intensive care units in resource-rich regions due to advanced procedures such as transplantation, cardiac surgery, and other hospital-acquired causes, to primary care preventable causes, such as infectious diseases, snakebite, and so forth in rural parts of the developing world. The development and application of novel biomarkers, concepts such as the Renal Angina Index and advanced renal replacement therapy have revolutionized the era of treating AKI, but the cost and feasibility are the key determinants, especially in rural areas. In view of availability and expenses, peritoneal dialysis should be the first choice in less-developed areas, however, because of various barriers, it still needs more effort. Effective educational steps to both medical carers and families are needed urgently.
Collapse
Affiliation(s)
- Ruochen Che
- Department of Nephrology, State Key Laboratory of Reproductive Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China
| | - Mohammed Mazheruddin Quadri
- Department of Nephrology, State Key Laboratory of Reproductive Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China
| | - Aihua Zhang
- Department of Nephrology, State Key Laboratory of Reproductive Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China.
| |
Collapse
|
20
|
Abstract
Acute kidney injury (AKI) is a highly prevalent disease entity in the NICU, affecting nearly one-quarter of critically ill neonates by some reports. Though medical management remains the mainstay in the treatment of AKI, renal replacement therapy (RRT) is indicated when conservative measures are unable to maintain electrolytes, fluid balance, toxins, or waste products within a safe margin. Several modalities of RRT exist for use in neonatal populations, including peritoneal dialysis, hemodialysis, and continuous RRT. It is the aim of this review to introduce each of these RRT modalities, as well as to discuss their technical considerations, benefits, indications, contraindications, and complications.
Collapse
Affiliation(s)
| | - Jason M Misurac
- Division of Nephrology, Dialysis, and Transplantation, University of Iowa Stead Family Children's Hospital, Iowa City, IA
| |
Collapse
|
21
|
Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort Study. Crit Care Med 2020; 47:e893-e901. [PMID: 31464768 PMCID: PMC6798750 DOI: 10.1097/ccm.0000000000003973] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Supplemental Digital Content is available in the text. Acute kidney injury requiring continuous renal replacement therapy is a serious treatment-related complication in pediatric cancer and hematopoietic stem cell transplant patients. The purpose of this study was to assess epidemiology and outcome of these patients requiring continuous renal replacement therapy in the PICU.
Collapse
|
22
|
Okan MA, Topçuoglu S, Karadag NN, Ozalkaya E, Karatepe HO, Vardar G, Celayir A, Karatekin G. Acute Peritoneal Dialysis in Premature Infants. Indian Pediatr 2020. [DOI: 10.1007/s13312-020-1815-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
23
|
Dialysis modalities for the management of pediatric acute kidney injury. Pediatr Nephrol 2020; 35:753-765. [PMID: 30887109 DOI: 10.1007/s00467-019-04213-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/04/2018] [Revised: 01/19/2019] [Accepted: 02/08/2019] [Indexed: 01/11/2023]
Abstract
Acute kidney injury (AKI) is an increasingly frequent complication among hospitalized children. It is associated with high morbidity and mortality, especially in neonates and children requiring dialysis. The different renal replacement therapy (RRT) options for AKI have expanded from peritoneal dialysis (PD) and intermittent hemodialysis (HD) to continuous RRT (CRRT) and hybrid modalities. Recent advances in the provision of RRT in children allow a higher standard of care for increasingly ill and young patients. In the absence of evidence indicating better survival with any dialysis method, the most appropriate dialysis choice for children with AKI is based on the patient's characteristics, on dialytic modality performance, and on the institutional resources and local practice. In this review, the available dialysis modalities for pediatric AKI will be discussed, focusing on indications, advantages, and limitations of each of them.
Collapse
|
24
|
Aygun F. Evaluation of continuous renal replacement therapy and risk factors in the pediatric intensive care unit. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION 2020; 31:53-61. [DOI: 10.4103/1319-2442.279961] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
25
|
Persic V, Vajdic Trampuz B, Medved B, Pavcnik M, Ponikvar R, Gubensek J. Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: Focus on citrate accumulation. Artif Organs 2019; 44:497-503. [PMID: 31851381 DOI: 10.1111/aor.13619] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2019] [Revised: 11/02/2019] [Accepted: 12/12/2019] [Indexed: 01/23/2023]
Abstract
Continuous renal replacement therapy (CRRT) with regional citrate anticoagulation (RCA) in newborns and infants is challenging and accumulation of citrate can occur. There are only a few studies reporting the detailed data on RCA. We aimed to analyze RCA-CRRT at our institution with focus on citrate accumulation. Critically ill newborns and infants up to 11 kg of body weight (BW), treated with RCA-CRRT in the 2011-2016 period were included in this retrospective observational study. Prismaflex(R) and Multifiltrate-CiCa(R) dialysis monitors were used with either automated or manual RCA. Data was collected regarding the circuit lifetime, parameters of RCA, markers of citrate accumulation (total/ionized calcium ratio > 2.5), and metabolic complications. We included 10 children with mean age of 2.6 ± 3.8 months and BW of 4.6 ± 2.7 kg. In-hospital mortality was 60%. RCA-CRRT parameters were: blood flow 46 ± 9 mL/min (12 ± 5 mL/min/kg BW), citrate dose 2.8 ± 0.6 mmol/L of blood resulting in estimated citrate load to the patient of 1.7 ± 0.8 mmol/h/kg BW. In total, 57 dialysis circuits were used with mean filter lifetime of 39 ± 29 h. Citrate accumulation (total/ionized calcium ratio > 2.5) was observed in 7/10 patients and in 14/57 (25%) of circuits; those circuits were performed in children with lower age and BW, had higher relative blood flow and citrate load, while citrate dose was similar. When citrate load to the patient was used to predict citrate accumulation, AUC under the ROC curve was 0.78 and 1.7 mmol/h/kg BW was considered the optimal cutoff value (sensitivity 71% and specificity 72%). CRRT with RCA using equipment, developed for adult population, is feasible in newborns and infants. Signs of citrate accumulation developed relatively often. To prevent it, we suggest avoiding citrate loads above 1.7 mmol/h/kg BW, which can best be achieved by keeping the blood flow below 9 mL/min/kg BW.
Collapse
Affiliation(s)
- Vanja Persic
- Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia.,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Barbara Vajdic Trampuz
- Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia.,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Bojan Medved
- Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia.,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Maja Pavcnik
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.,Department of Pediatric Surgery and Intensive Care, University Medical Center Ljubljana, Ljubljana, Slovenia
| | - Rafael Ponikvar
- Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia.,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Jakob Gubensek
- Department of Nephrology, University Medical Center Ljubljana, Ljubljana, Slovenia.,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| |
Collapse
|
26
|
Company-Albir MJ, García-Robles A, Torres-Martinez E, Marqués-Miñana MR, Vento-Torres M, Poveda JL. Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report. J Clin Pharm Ther 2019; 44:647-649. [PMID: 31032996 DOI: 10.1111/jcpt.12842] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2019] [Accepted: 04/08/2019] [Indexed: 11/29/2022]
Abstract
WHAT IS KNOWN AND OBJECTIVE Guidelines for prevention and treatment of peritonitis in paediatric patients recommend vancomycin. We present the clinical practice in neonates during peritoneal dialysis and evaluate dosage and serum levels of vancomycin. CASE SUMMARY This case report describes a newborn with acute renal failure under continuous peritoneal dialysis therapy and intraperitoneal vancomycin. We report the treatment dosage and serum vancomycin levels. WHAT IS NEW AND CONCLUSION There is great variability in the recommended dose of vancomycin for continuous peritoneal dialysis and the available clinical experience. Further investigation of dosing in children particularly in newborns, especially in loading dose, is necessary.
Collapse
Affiliation(s)
- María José Company-Albir
- Pharmacy Department, Health Research Institute La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Ana García-Robles
- Neonatal Research Group, Health Research Institute La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - Ester Torres-Martinez
- Neonatal Research Group, Health Research Institute La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain.,Division of Neonatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
| | | | - Máximo Vento-Torres
- Neonatal Research Group, Health Research Institute La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain.,Division of Neonatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
| | - José Luis Poveda
- Pharmacy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
| |
Collapse
|
27
|
Guzzo I, de Galasso L, Mir S, Bulut IK, Jankauskiene A, Burokiene V, Cvetkovic M, Kostic M, Bayazit AK, Yildizdas D, Schmitt CP, Paglialonga F, Montini G, Yilmaz E, Oh J, Weber L, Taylan C, Hayes W, Shroff R, Vidal E, Murer L, Mencarelli F, Pasini A, Teixeira A, Afonso AC, Drozdz D, Schaefer F, Picca S. Acute dialysis in children: results of a European survey. J Nephrol 2019; 32:445-451. [PMID: 30949986 DOI: 10.1007/s40620-019-00606-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2019] [Accepted: 03/28/2019] [Indexed: 12/21/2022]
Abstract
The number of children with acute kidney injury (AKI) requiring dialysis is increasing. To date, systematic analysis has been largely limited to critically ill children treated with continuous renal replacement therapy (CRRT). We conducted a survey among 35 European Pediatric Nephrology Centers to investigate dialysis practices in European children with AKI. Altogether, the centers perform dialysis in more than 900 pediatric patients with AKI per year. PD and CRRT are the most frequently used dialysis modalities, accounting for 39.4% and 38.2% of treatments, followed by intermittent HD (22.4%). In units treating more than 25 cases per year and in those with cardiothoracic surgery programs, PD is the most commonly chosen dialysis modality. Also, nearly one quarter of centers, in countries with a gross domestic product below $35,000/year, do not utilize CRRT at all. Dialysis nurses are exclusively in charge of CRRT management in 45% of the cases and pediatric intensive care nurses in 25%, while shared management is practiced in 30%. In conclusion, this survey indicates that the choice of treatment modalities for dialysis in children with AKI in Europe is affected by the underlying ethiology of the disease, organization/set-up of centers and socioeconomic conditions. PD is utilized as often as CRRT, and also intermittent HD is a commonly applied treatment option. A prospective European AKI registry is planned to provide further insights on the epidemiology, management and outcomes of dialysis in pediatric AKI.
Collapse
Affiliation(s)
- Isabella Guzzo
- Nephrology and Dialysis Unit, Pediatric Subspecialties Department, Institute for Scientific Research, Bambino Gesù Children's Hospital, Piazza S. Onofrio 4, 00165, Rome, Italy.
| | - Lara de Galasso
- Nephrology and Dialysis Unit, Pediatric Subspecialties Department, Institute for Scientific Research, Bambino Gesù Children's Hospital, Piazza S. Onofrio 4, 00165, Rome, Italy
| | - Sevgi Mir
- Ege University Faculty of Medicine, Izmir, Turkey
| | | | - Augustina Jankauskiene
- Clinic of Children Diseases, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
| | - Vilmanta Burokiene
- Children Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
| | | | | | - Aysun Karabay Bayazit
- Department of Pediatric Nephrology, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Dincer Yildizdas
- Department of Pediatric Nephrology, Cukurova University Faculty of Medicine, Adana, Turkey
| | - Claus Peter Schmitt
- Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany
| | - Fabio Paglialonga
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Giovanni Montini
- Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | | | - Jun Oh
- University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Lutz Weber
- Children's and Adolescents' Hospital, University Hospital of Cologne, Cologne, Germany
| | - Christina Taylan
- Children's and Adolescents' Hospital, University Hospital of Cologne, Cologne, Germany
| | - Wesley Hayes
- Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK
| | - Rukshana Shroff
- Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK
| | - Enrico Vidal
- Azienda Ospedaliera-University of Padua, Padua, Italy
| | - Luisa Murer
- Azienda Ospedaliera-University of Padua, Padua, Italy
| | | | | | - Ana Teixeira
- Centro Materno-Infantil do Norte, Porto, Portugal
| | | | - Dorota Drozdz
- Jagiellonian University Medical College, Krakow, Poland
| | - Franz Schaefer
- Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany
| | - Stefano Picca
- Nephrology and Dialysis Unit, Pediatric Subspecialties Department, Institute for Scientific Research, Bambino Gesù Children's Hospital, Piazza S. Onofrio 4, 00165, Rome, Italy
| |
Collapse
|
28
|
Sethi SK, Krishnappa V, Nangethu N, Nemer P, Frazee LA, Raina R. Antibiotic Dosing in Sustained Low-Efficiency Dialysis in Critically Ill Patients. Can J Kidney Health Dis 2018; 5:2054358118792229. [PMID: 30116545 PMCID: PMC6088477 DOI: 10.1177/2054358118792229] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Accepted: 06/14/2018] [Indexed: 11/16/2022] Open
Abstract
Purpose of review Sustained low-efficiency dialysis (SLED) is increasingly used as a renal replacement modality in critically ill patients with acute kidney injury (AKI) and hemodynamic instability. There is, therefore, a greater need for the understanding of the antibiotic dosage and pharmacokinetics in these patients, to provide them with optimal therapy. Sources of information PubMed/Medline, Embase, and Google Scholar. Methods PubMed/Medline, Embase, and Google Scholar databases were searched using a combination of key words: dialysis, end stage renal disease, renal failure, sustained low efficiency dialysis, extended daily dialysis, prolonged intermittent renal replacement therapy (PIRRT), and antibiotic dosing. Studies that investigated antibiotic dosing and pharmacokinetics during SLED/extended daily dialysis/PIRRT were selected for this review. Key findings Eleven studies met inclusion criteria and selected for data extraction. The data with regard to dialysis specifications, type of antibiotic including dosages, drug clearances, and dosage recommendations are summarized in Table 1. It is a challenge to find therapeutic doses for antibiotics during SLED therapy because, in general, only aminoglycosides and vancomycin can be assayed in clinical laboratories. Limitations Although current studies on antibiotic dosing in SLED are limited due to diverse and undersized patient populations, antibiotic dosage adjustments for patients receiving SLED discussed here will serve as a valuable guide. Future large-scale research should focus on establishing guidelines for antibiotic dosage in SLED. Implications Pharmacokinetic principles should be taken into consideration for the appropriate dosing of drugs during SLED, yet it is vital to monitor response to drug to make sure therapeutic goals are achieved. Antibiotic dosing and timing relative to the initiation of SLED may be important to maximize either the time above the minimum inhibitory concentration (MIC) (time-dependent) or the peak to MIC ratio (concentration-dependent), balancing efficacy and toxicity concerns. Critical care physicians should liaise with nephrologists to make decisions regarding appropriate antibiotic dosing in patients undergoing SLED.
Collapse
Affiliation(s)
- Sidharth Kumar Sethi
- Pediatric Nephrology, Kidney Institute, Medanta the Medicity, Gurgaon, Haryana, India
| | - Vinod Krishnappa
- Cleveland Clinic Akron General/Akron Nephrology Associates, OH, USA.,Northeast Ohio Medical University, Rootstown, OH, USA
| | - Nisha Nangethu
- Cleveland Clinic Akron General/Akron Nephrology Associates, OH, USA
| | - Paul Nemer
- Cleveland Clinic Akron General/Akron Nephrology Associates, OH, USA
| | | | - Rupesh Raina
- Cleveland Clinic Akron General/Akron Nephrology Associates, OH, USA.,Department of Nephrology, Cleveland Clinic Akron General and Akron Children's Hospital, OH, USA
| |
Collapse
|
29
|
Keenswijk W, Vande Walle J. A 2-year-old boy with circulatory failure owing to streptococcal toxic shock syndrome: case report. Paediatr Int Child Health 2018; 38:223-226. [PMID: 28426384 DOI: 10.1080/20469047.2017.1315913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
A 2-year-old boy presented with severe hypotension and acute kidney injury after a prodrome of non-bloody diarrhoea and fever in the preceding 3 days. He had a mild Ebstein cardiac anomaly but otherwise a normal past history and growth. On examination, he looked ill, his temperature was 37.5 °C, circulation was poor, and there were several purpuric lesions on the face, hands and scrotum. Haemoglobin was 7.8 g/dL (11-14), total white cell count 27 × 109/L, platelets 62 × 109/L, blood urea nitrogen 20.7 mmol/L (4.2-17.1), serum creatinine 95.4 μmol/L (21.2-36.2), CRP 154 mg/L (<5), AST 296 U/L (11-50), ALT 909 U/L (7-40) and C3 component of complement 0.8 g/L (0.9-1.8). Activated partial thromboplastin time (APTT) and prothrombin time (PT) were prolonged and fibrinogen level was 1.0 g/L (2-4). He received immediate fluid resuscitation (IV 0.9% saline solution, 2 × 10 ml/kg boluses, followed by glucose 5/0.45% sodium chloride solution, 2 × 10 ml/kg) and antibiotics (ciprofloxacin and amikacin) but circulation continued to deteriorate with development of decreased consciousness. He was placed on mechanical ventilation and vasopressor agents were added. Despite improved circulation over the next 2 days, he developed oliguria, progressive fluid overload, generalised oedema and a right-sided pleural effusion. Dialysis was commenced on day 3 of admission. Differential diagnosis included sepsis, atypical haemolytic uraemic syndrome and lupus nephritis. Blood and urine cultures remained negative but an anti-streptolysin O titre of 1318 (<200) IU/mL led to the diagnosis of streptococcal toxic shock syndrome which is rare in early childhood and associated with high mortality. Haemodialysis was commenced and continued for 10 days with successful treatment of fluid overload and subsequent extubation. Renal function was completely restored over the following 6 weeks and he was discharged in good clinical condition about 2 months after intial admission. The clinical course and outcome are discussed, and the importance of timely initiation of dialysis when there is fluid overload is emphasised.
Collapse
Affiliation(s)
- Werner Keenswijk
- a Department of Pediatrics , sLands Hospitaal Suriname , Paramaribo , Suriname.,b Department of Pediatrics , Ghent University Hospital , Ghent , Belgium
| | - Johan Vande Walle
- b Department of Pediatrics , Ghent University Hospital , Ghent , Belgium
| |
Collapse
|
30
|
Sinha R, Sethi SK, Bunchman T, Lobo V, Raina R. Prolonged intermittent renal replacement therapy in children. Pediatr Nephrol 2018; 33:1283-1296. [PMID: 28721515 DOI: 10.1007/s00467-017-3732-2] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Revised: 05/22/2017] [Accepted: 05/31/2017] [Indexed: 12/15/2022]
Abstract
Wide ranges of age and weight in pediatric patients makes renal replacement therapy (RRT) in acute kidney injury (AKI) challenging, particularly in the pediatric intensive care unit (PICU), wherein children are often hemodynamically unstable. Standard hemodialysis (HD) is difficult in this group of children and continuous veno-venous hemofiltration/dialysis (CVVH/D) has been the accepted modality in the developed world. Unfortunately, due to cost constraints, CVVH/D is often not available and peritoneal dialysis (PD) remains the common mode of RRT in resource-poor facilities. Acute PD has its drawbacks, and intermittent HD (IHD) done slowly over a prolonged period has been explored as an alternative. Various modes of slow sustained IHD have been described in the literature with the recently introduced term prolonged intermittent RRT (PIRRT) serving as an umbrella terminology for all of these modes. PIRRT has been widely accepted in adults with studies showing it to be as effective as CVVH/D but with an added advantage of being more cost-effective. Pediatric data, though scanty, has been promising. In this current review, we elaborate on the practical aspects of undertaking PIRRT in children as well as summarize its current status.
Collapse
Affiliation(s)
- Rajiv Sinha
- Institute of Child Health and AMRI Hospital, 37, G Bondel Road, Kolkata, West Bengal, 700019, India.
| | - Sidharth Kumar Sethi
- Pediatric Nephrology, Kidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India
| | - Timothy Bunchman
- Pediatric Nephrology, Children's Hospital of Richmond at VCU, Richmond, VA, USA
| | - Valentine Lobo
- Department of Nephrology, KEM Hospital, Pune, Maharashtra, India
| | - Rupesh Raina
- Pediatric Nephrology, Akron Children's Hospital, Cleveland, OH, USA
| |
Collapse
|
31
|
Peritoneal dialysis beyond kidney failure? J Control Release 2018; 282:3-12. [DOI: 10.1016/j.jconrel.2018.01.017] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2017] [Accepted: 01/17/2018] [Indexed: 12/19/2022]
|
32
|
Raina R, Vijayaraghavan P, Kapur G, Sethi SK, Krishnappa V, Kumar D, Bunchman TE, Bolen SD, Chand D. Hemodialysis in neonates and infants: A systematic review. Semin Dial 2017; 31:289-299. [DOI: 10.1111/sdi.12657] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Rupesh Raina
- Department of Nephrology; Cleveland Clinic Akron General/Akron Nephrology Associates; Akron OH USA
- Department of Pediatric Nephrology; Akron Children's Hospital; Akron OH USA
| | - Prashanth Vijayaraghavan
- Department of Nephrology; Cleveland Clinic Akron General/Akron Nephrology Associates; Akron OH USA
| | - Gaurav Kapur
- Pediatric Nephrology and Hypertension; Children's Hospital of Michigan; Detroit MI USA
| | - Sidharth Kumar Sethi
- Pediatric Nephrology & Pediatric Kidney Transplantation; Kidney and Urology Institute; Medanta, The Medicity Hospital; Gurgaon India
| | - Vinod Krishnappa
- Department of Nephrology; Cleveland Clinic Akron General/Akron Nephrology Associates; Akron OH USA
| | - Deepak Kumar
- Division of Pediatric Neonatology; MetroHealth Medical Center/Case Western Reserve University; Cleveland OH USA
| | - Timothy E. Bunchman
- Pediatric Nephrology & Transplantation; Children's Hospital of Richmond; Virginia Commonwealth University; Richmond VA USA
| | - Shari D Bolen
- Center for Health Care Research and Policy; Department of Medicine; Metro Health Medical Center/Case Western Reserve University; Cleveland OH USA
| | - Deepa Chand
- Division of Pediatric Nephrology; University of Illinois College of Medicine; Peoria IL USA
| |
Collapse
|
33
|
Liposome-supported enzymatic peritoneal dialysis. Biomaterials 2017; 145:128-137. [DOI: 10.1016/j.biomaterials.2017.08.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2017] [Revised: 08/08/2017] [Accepted: 08/14/2017] [Indexed: 11/19/2022]
|
34
|
Rus RR, Premru V, Novljan G, Grošelj-Grenc M, Ponikvar R. Fate of Central Venous Catheters Used for Acute Extracorporeal Treatment in Critically Ill Pediatric Patients: A Single Center Experience. Ther Apher Dial 2017; 20:308-11. [PMID: 27312920 DOI: 10.1111/1744-9987.12442] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Accepted: 03/23/2016] [Indexed: 11/28/2022]
Abstract
Renal replacement treatment (RRT) is required in severe acute kidney injury, and a functioning central venous catheter (CVC) is crucial. Twenty-eight children younger than 16 years have been treated at the University Medical Centre Ljubljana between 2003 and 2012 with either acute hemodialysis (HD) and/or plasma exchange (PE), and were included in our study. The age of the patients ranged from 2 days to 14.1 years. Sixty-six CVCs were inserted (52% de novo, 48% guide wire). The sites of insertion were the jugular vein in 20% and the femoral vein in 80%. Catheters were in function from 1 day to 27 days. The most common cause for CVC removal or exchange was catheter dysfunction (50%). CVCs were mostly inserted in the femoral vein, which is the preferred site of insertion in acute HD/PE because of the smaller number of complications.
Collapse
Affiliation(s)
- Rina R Rus
- Department of Nephrology, Division of Paediatrics, University Medical Centre, Ljubljana, Slovenia
| | - Vladimir Premru
- Department of Nephrology, Division of Internal Clinics, University Medical Centre, Ljubljana, Slovenia
| | - Gregor Novljan
- Department of Nephrology, Division of Paediatrics, University Medical Centre, Ljubljana, Slovenia.,Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Mojca Grošelj-Grenc
- Department of Paediatric Surgery and Intensive Care, Division of Surgery, University Medical Centre, Ljubljana, Slovenia
| | - Rafael Ponikvar
- Department of Nephrology, Division of Internal Clinics, University Medical Centre, Ljubljana, Slovenia
| |
Collapse
|
35
|
Infection in critically ill pediatric patients on continuous renal replacement therapy. Int J Artif Organs 2017; 40:224-229. [PMID: 28525671 DOI: 10.5301/ijao.5000587] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/17/2017] [Indexed: 01/20/2023]
Abstract
INTRODUCTION Continuous renal replacement therapies (CRRT) are frequently used in critically ill children and may increase the risk of infection. However, the incidence, characteristics and prognosis of infection in critically ill children on CRRT have not been studied. METHODS Data from a prospective, single-center register of critically ill children treated with CRRT was analyzed. RESULTS 55 children (40% under 1 year of age) were treated with CRRT between June 2008 and January 2012; 43 patients (78.2%) presented 1 or more infections. The most common condition of patients requiring CRRT was heart disease (69%). Infection occurred a median of 11 days after the initiation of CRRT (IQ range: 4 to 21 days). A total of 21 patients (48.8 %) developed 1 infection, 7 (16.2%) developed 2 infections and 15 (34.9%) developed 3 or more infections. The most frequent infection was catheter-related bacteremia, with no differences in catheter location. CRRT duration longer than 4.5 days was the only risk factor for infection. Patients with infection had a longer length of stay (LOS) in the Pediatric Intensive Care Unit (PICU) than patients without it (37.8 vs. 17.6, p = 0.019), but there were no differences in mortality (30.2% vs. 33.3%; p = 0.84). CONCLUSIONS Infection rate is high in critically ill children treated with CRRT. More than 4 days of CRRT increases the risk of infection. Infection in these patients entails a longer stay in the PICU but did not increase mortality.
Collapse
|
36
|
Choi SJ, Ha EJ, Jhang WK, Park SJ. Factors Associated With Mortality in Continuous Renal Replacement Therapy for Pediatric Patients With Acute Kidney Injury. Pediatr Crit Care Med 2017; 18:e56-e61. [PMID: 28157807 DOI: 10.1097/pcc.0000000000001024] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
OBJECTIVES To analyze the epidemiology of pediatric acute kidney injury requiring continuous renal replacement therapy and identify prognostic factors affecting mortality rates. DESIGN Retrospective analysis. SETTING PICU of a tertiary medical center. PATIENTS One hundred-twenty three children diagnosed with acute kidney injury requiring continuous renal replacement therapy. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Vasoactive-Inotropic Score, arterial blood gas analysis, blood chemistry at continuous renal replacement therapy initiation, the extent of fluid overload 24 hours prior to continuous renal replacement therapy initiation, Pediatric Risk of Mortality III score at admission, and need for mechanical ventilation during continuous renal replacement therapy were compared in survivors and nonsurvivors. Out of 1,832 patient admissions, 185 patients (10.1%) developed acute kidney injury during the study period. Of these, 158 patients were treated with continuous renal replacement therapy, and finally, 123 patients were enrolled. Of the enrolled patients, 50 patients died, corresponding to a mortality rate of 40.6%. The survivor group and the nonsurvivor group were compared, and the following factors were associated with an increased risk of mortality: higher Pediatric Risk of Mortality III score at admission and Vasoactive-Inotropic Score when initiating continuous renal replacement therapy, increased fluid overload 24 hours before continuous renal replacement therapy initiation, and need for mechanical ventilation during continuous renal replacement therapy. The percentage of fluid overload difference between the survivors and the nonsurvivors was 1.2% ± 2.2% versus 4.1% ± 4.6%, respectively. Acidosis, elevated lactic acid and blood urea nitrogen, and lower serum creatinine level were laboratory parameters associated with increased mortality. On multivariate analysis, Vasoactive-Inotropic Score, need for mechanical ventilation, blood urea nitrogen, and creatinine level were statistically significant. (Odds ratio: 1.040, 6.096, 1.032, and 0.643, respectively.) CONCLUSIONS:: A higher Vasoactive-Inotropic Score, need for mechanical ventilation, elevated blood urea nitrogen, and lower creatinine level were associated with increased mortality in pediatric acute kidney injury patients who underwent continuous renal replacement therapy. Lower creatinine levels may be associated with increased mortality in the context of fluid overload, which is correlated with a reduced chance of survival.
Collapse
Affiliation(s)
- Seung Jun Choi
- All authors: Division of Pediatric Critical Care Medicine, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Songpa-gu, Seoul, Republic of Korea
| | | | | | | |
Collapse
|
37
|
Lorenzin A, Garzotto F, Alghisi A, Neri M, Galeano D, Aresu S, Pani A, Vidal E, Ricci Z, Murer L, Goldstein SL, Ronco C. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations. Pediatr Nephrol 2016; 31:1659-65. [PMID: 27139897 DOI: 10.1007/s00467-016-3397-2] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2016] [Revised: 04/13/2016] [Accepted: 04/14/2016] [Indexed: 10/21/2022]
Abstract
BACKGROUND The CARdiorenal PEDIatric EMergency (CARPEDIEM) machine was originally designed to perform only continuous venovenous hemofiltration (CVVH) in neonatal and pediatric patients. In some cases, adequate convective clearance may not be reached because of a limited blood flow. In such conditions, the application of diffusive clearance [continuous venovenous hemodialysis (CVVHD)] would help optimize blood purification. In this study, the CARPEDIEM™ machine was modified to enable the circulation of dialysis through the filter allowing testing of the performance of CARPEDIEM™ machine in CVVHD. METHODS Three different polyethersulfone hemodialyzers (surface area = 0.1 m(2), 0.2 m(2), and 0.35 m(2), respectively) were tested in vitro with a scheduled combination of plasma flow rates (Qp = 10-20-30 ml/min) and dialysis fluid flow rate (Qd = 5-10-15 ml/min). Three sessions were performed in co-current and one in counter-current configuration (as control) for each filter size. Clearance was measured from the blood and dialysate sides and results with mass balance error greater than 5 % were discarded. RESULTS Urea and creatinine clearances for each plasma/dialysate combination are reported: clearance increase progressively for every filter proportionally to plasma flow rates. Similarly, clearances increase progressively with dialysate flow rates at a given plasma flow. The clearance curve tends to present a steep increase for small increases in plasma flow in the range below 10 ml/min, while the curve tends to plateau for values averaging 30 ml/min. As expected, the plateau is reached earlier with the smaller filter showing the effect of membrane surface-area limitation. At every plasma flow, the effect of dialysate flow increase is evident and well defined, showing that saturation of effluent was not achieved completely in any of the experimental conditions explored. No differences (p > 0.05 for all values) were obtained in experiments using whole blood instead of plasma or using co-current versus counter-current dialysate flow configuration. CONCLUSIONS Although plasma flow and filter surface give an important contribution to the level of clearance urea and creatinine, it appears evident that dialysate flow plays an essential role in the blood purification process, justifying the use of CVVHD versus CVVH in case of high dialysis dose requirement and/or limited blood flow rate.
Collapse
Affiliation(s)
- Anna Lorenzin
- International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy
| | - Francesco Garzotto
- International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy
| | - Alberta Alghisi
- Department of Immunology and Blood Transfusions, San Bortolo Hospital, Vicenza, Italy
| | - Mauro Neri
- International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy
| | - Dario Galeano
- International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy
| | - Stefania Aresu
- Nephrology, Dialysis and Transplantation "G. Brotzu" Hospital, Cagliari, Italy
| | - Antonello Pani
- Nephrology, Dialysis and Transplantation "G. Brotzu" Hospital, Cagliari, Italy
| | - Enrico Vidal
- Nephrology, Dialysis and Transplant Unit, Department of Woman's and Child's Health, Hospital and University of Padova, Padova, Italy
| | - Zaccaroa Ricci
- Department of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Luisa Murer
- Nephrology, Dialysis and Transplant Unit, Department of Woman's and Child's Health, Hospital and University of Padova, Padova, Italy
| | - Stuart L Goldstein
- Center for Acute Care Nephrology, Cincinnati Children's Hospital, Cincinnati, OH, USA.
| | - Claudio Ronco
- International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy.,Department of Immunology and Blood Transfusions, San Bortolo Hospital, Vicenza, Italy.,Nephrology, Dialysis and Transplantation "G. Brotzu" Hospital, Cagliari, Italy.,Nephrology, Dialysis and Transplant Unit, Department of Woman's and Child's Health, Hospital and University of Padova, Padova, Italy.,Department of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.,Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy
| |
Collapse
|
38
|
Nourse P, Sinclair G, Gajjar P, du Plessis M, Argent AC. Continuous flow peritoneal dialysis (CFPD) improves ultrafiltration in children with acute kidney injury on conventional PD using a 4.25 % dextrose solution. Pediatr Nephrol 2016; 31:1137-43. [PMID: 26879802 DOI: 10.1007/s00467-016-3341-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2015] [Revised: 01/16/2016] [Accepted: 02/01/2016] [Indexed: 10/22/2022]
Abstract
BACKGROUND Criticism against the use of acute peritoneal dialysis (PD) has been its low clearance and low ultrafiltration (UF) volumes compared to extracorporeal techniques. The aim of our study was to determine whether continuous flow peritoneal dialysis (CFPD) would improve UF in children with acute kidney injury (AKI) in cases where UF on conventional PD was inadequate using 4.25 % glucose concentrations. METHODS Five infants were prospectively studied. All had AKI with fluid overload. The median age of the patients was 6 (range 0.43-9) months; the median weight was 6.5 (range 2.7-8.4) kg. Each patient served as his or her own control, undergoing both CFPD and conventional PD. CFPD was performed with two bedside-placed catheters using a 2.5 % glucose concentration. After initial filling, a dialysate flow rate of 100 ml/min/1.73 m(2) was maintained with an adapted continuous venovenous haemofiltration machine. The UF flow rate was set at 2.5 ml/min/1.73 m(2) and adapted as necessary. UF and clearance rates were measured for both PD and CFPD. RESULTS The median UF rate achieved was 1.7 (range 0.01-5.30) mg/kg/h with conventional PD versus 6.7 (range 2.17-15.7) mg/kg/h with CFPD (p = 0.042). The clearances of urea and creatinine were 6.89 (range 4.50-7.55) and 7.46 (range 4.79-10.50) mL/min/1.73 m(2), respectively, with conventional PD and 19 (17.0-30.0) and 41 (standard deviation17.4, range 12.0-52.0) mL/min/1.73 m(2), respectively, with CFPD (both p = 0.043). CONCLUSION Continuous flow peritoneal dialysis improves UF in fluid overloaded infants who are not achieving adequate UF on conventional PD.
Collapse
Affiliation(s)
- Peter Nourse
- Division of Paediatric Nephrology, Red Cross War Memorial Children's Hospital, University of Cape Town, Klipfontein road, Rondebosch, Cape Town, 7700, South Africa.
| | - Gina Sinclair
- Division of Paediatric Nephrology, Red Cross War Memorial Children's Hospital, University of Cape Town, Klipfontein road, Rondebosch, Cape Town, 7700, South Africa
| | - Priya Gajjar
- Division of Paediatric Nephrology, Red Cross War Memorial Children's Hospital, University of Cape Town, Klipfontein road, Rondebosch, Cape Town, 7700, South Africa
| | - Mandi du Plessis
- Division of Paediatric Intensive Care, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa
| | - Andrew Charles Argent
- Division of Paediatric Intensive Care, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa
| |
Collapse
|
39
|
Maizlin II, Shroyer MC, Perger L, Chen MK, Beierle EA, Martin CA, Anderson SA, Mortellaro VE, Rogers DA, Russell RT. Outcome assessment of renal replacement therapy in neonates. J Surg Res 2016; 204:34-8. [DOI: 10.1016/j.jss.2016.04.031] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2016] [Revised: 03/26/2016] [Accepted: 04/15/2016] [Indexed: 11/28/2022]
|
40
|
Fluid Overload Is Associated With Higher Mortality and Morbidity in Pediatric Patients Undergoing Cardiac Surgery. Pediatr Crit Care Med 2016; 17:307-14. [PMID: 26914622 DOI: 10.1097/pcc.0000000000000659] [Citation(s) in RCA: 70] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
OBJECTIVES Fluid overload after pediatric cardiac surgery is common and has been shown to increase both mortality and morbidity. This study explores the risk factors of early postoperative fluid overload and its relationship with adverse outcomes. DESIGN Secondary analysis of the prospectively collected data of children undergoing open-heart surgery between 2004 and 2008. SETTING Tertiary national cardiac center. PATIENTS One thousand five hundred twenty consecutive pediatric patients (<18 years old) were included in the analyses. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS In the first 72 hours of the postoperative period, the daily fluid balance was calculated as milliliter per kilogram and the daily fluid overload was calculated as fluid balance (L)/weight (kg) × 100. The primary endpoint was in-hospital mortality; the secondary outcomes were low cardiac output syndrome and prolonged mechanical ventilation. One thousand three hundred and sixty-seven patients (89.9%) had a cumulative fluid overload below 5%; 120 patients (7.8%), between 5% and 10%; and 33 patients (2.1%), above 10%. After multivariable analysis, higher fluid overload on the day of the surgery was independently associated with mortality (adjusted odds ratio, 1.14; 95% CI, 1.008-1.303; p = 0.041) and low cardiac output syndrome (adjusted odds ratio, 1.21; 95% CI, 1.12-1.30; p = 0.001). Higher maximum serum creatinine levels (adjusted odds ratio, 1.01; 95% CI, 1.003-1.021; p = 0.009), maximum vasoactive-inotropic scores (adjusted odds ratio, 1.01; 95% CI, 1.005-1.029; p = 0.042), and higher blood loss on the day of the surgery (adjusted odds ratio, 1.01; 95% CI, 1.004-1.025; p = 0.015) were associated with a higher risk of fluid overload that was greater than 5%. CONCLUSIONS Fluid overload in the early postoperative period was associated with higher mortality and morbidity. Risk factors for fluid overload include underlying kidney dysfunction, hemodynamic instability, and higher blood loss on the day of the surgery.
Collapse
|
41
|
Jetton JG, Rhone ET, Harer MW, Charlton JR, Selewski DT. Diagnosis and Treatment of Acute Kidney Injury in Pediatrics. ACTA ACUST UNITED AC 2016. [DOI: 10.1007/s40746-016-0047-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
42
|
Cavagnaro Santa María F, Roque Espinosa J, Guerra Hernández P, Smith Torres M, González Largo I, Ronco Macchiavello R. [Continuous renal replacement therapy in newborns: Experience of a single centre]. REVISTA CHILENA DE PEDIATRIA 2015:S0370-4106(15)00183-7. [PMID: 26460084 DOI: 10.1016/j.rchipe.2015.07.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/04/2015] [Revised: 07/24/2015] [Accepted: 07/27/2015] [Indexed: 06/05/2023]
Affiliation(s)
- Felipe Cavagnaro Santa María
- Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile; Facultad de Medicina, Clínica Alemana - Universidad del Desarrollo, Santiago de Chile, Chile.
| | - Jorge Roque Espinosa
- Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile; Facultad de Medicina, Clínica Alemana - Universidad del Desarrollo, Santiago de Chile, Chile; Unidad de Cuidados Intensivos Pediátricos, Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile
| | - Pamela Guerra Hernández
- Unidad de Cuidados Intensivos Pediátricos, Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile
| | - Marta Smith Torres
- Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile; Unidad de Cuidados Intensivos Pediátricos, Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile
| | - Isabel González Largo
- Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile; Unidad de Cuidados Intensivos Pediátricos, Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile
| | - Ricardo Ronco Macchiavello
- Departamento de Pediatría, Clínica Alemana de Santiago, Santiago de Chile, Chile; Facultad de Medicina, Clínica Alemana - Universidad del Desarrollo, Santiago de Chile, Chile
| |
Collapse
|
43
|
Khandelwal P, Sharma S, Bhardwaj S, Thergaonkar RW, Sinha A, Hari P, Lodha R, Bagga A. Experience with Continuous Renal Replacement Therapy. Indian J Pediatr 2015; 82:752-4. [PMID: 25776002 DOI: 10.1007/s12098-015-1743-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2015] [Accepted: 03/02/2015] [Indexed: 11/29/2022]
Abstract
Information on provision of continuous renal replacement therapy (CRRT) in critically ill children from developing countries is limited. The authors describe their experience in 17 children with hypotension and acute kidney injury (AKI) with fluid overload or electrolyte imbalance managed by 20 sessions of CRRT. The median (range) age and weight were 6 y (0.75-18) and 20 kg (6.2-42), respectively. All patients were receiving inotropic agents; nine had fluid overload (19 %, range 11-34.1 %) and ten had severe AKI. Median clearance and filter-life were 2171.4 ml/1.73 m(2)/h (1730.6-4405.8) and 69.7 h (2.8-98.3), respectively. Complications were catheter flow related (n = 1), filter clotting (n = 3), hemorrhage (n = 3), hypokalemia (n = 16) and hypophosphatemia (n = 11). Eight patients (47.1 %) survived; the median PRISM III score of survivors was significantly lower than non survivors (10.5 vs.17.0; P 0.02). Renal function recovered in the survivors emphasizing the role of this modality in managing critically ill patients.
Collapse
Affiliation(s)
- Priyanka Khandelwal
- Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Shin HS, Oh JY, Park SJ, Kim JH, Lee JS, Shin JI. Outcomes of Hemodialysis in Children: A 35-Year Experience at Severance Hospital. Yonsei Med J 2015; 56:1007-14. [PMID: 26069124 PMCID: PMC4479829 DOI: 10.3349/ymj.2015.56.4.1007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
PURPOSE The aim of this study was to analyze the results of children treated with hemodialysis (HD) at Severance Hospital over 35 years in terms of incidence, etiologies, characteristics, complications, and clinical outcomes. MATERIALS AND METHODS We analyzed 46 children admitted to Severance Hospital who had undergone HD between January 1979 and December 2013. RESULTS The main etiologies of the 23 end-stage renal disease (ESRD) patients who had received HD were chronic glomerulonephritis (7 patients, 30.4%) and congenital anomalies of the kidney and urinary tract (7 patients, 30.4%), whereas the etiology of the 23 acute kidney injury (AKI) patients was hemolytic uremic syndrome (6 patients, 26.1%). Compared with ESRD patients, hemocatheter placement in the femoral vein was preferred over the subclavian or internal jugular vein in the AKI patients (p=0.012). The most common complication was catheter related complication (10 patients, 21.7%). The site of hemocatheter insertion was not related to the frequency of oozing. Placing the hemocatheter in the femoral vein resulted in significantly more events of catheter obstruction than insertion in the internal jugular vein or the subclavian vein (p=0.001). Disequilibrium syndrome occurred more frequently in older patients (p=0.004), as well as patients with a greater body weight (p=0.008) and a higher systolic and diastolic blood pressure before HD (systolic: p=0.021; diastolic: p=0.040). CONCLUSION Based on the 35 years of experience in our center, HD can be sufficiently and safely carried out even in children without significant complications.
Collapse
Affiliation(s)
- Hyun-Seung Shin
- Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Ji Young Oh
- Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Se Jin Park
- Department of Pediatrics, Daewoo General Hospital, Ajou University School of Medicine, Geoje, Korea
| | - Ji Hong Kim
- Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jae Seung Lee
- Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jae Il Shin
- Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.
| |
Collapse
|
45
|
Kara OD, Dincel N, Kaplan Bulut I, Yilmaz E, Ozdemir K, Gozuoğlu G, Bicer H, Mir S. Success of continuous veno-venous hemodiafiltration treatment in children monitored in the intensive care units. Ren Fail 2015; 36:1411-5. [PMID: 25246342 DOI: 10.3109/0886022x.2014.950932] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
INTRODUCTION As intensive care units (ICU) have improved, presence of multiple-organ dysfunctions in majority of patients with acute renal failure (ARF) has become clearer. To facilitate multi-organ support, continuous renal replacement therapy (CRRT) techniques have been developed. This study is the one that reports the experience on children including newborns receiving CRRT monitored in ICU. MATERIALS AND METHODS The study was performed retrospectively in children who had Continuous Veno- Venous Hemodiafiltration (CVVHDF) as a CRRT modality in ICU. Clinical data, primary cause, consultation time, duration and initiation time of CVVHDF were recorded. Patients were classified as cardiac and non-cardiac in respect to primary dysfunction. Stage of renal failure was evaluated according to pRIFLE criteria. Outcome was identified as primary and secondary. Primary outcome was accepted as the composite correction of uremia and metabolic parameters, and regression of fluid overload, while secondary outcomes were assessed as improvement of hemodynamic instability and survival. RESULTS A total of 36 patients' files were scanned. There were 10 cases in cardiac group and 26 cases in non-cardiac group. There were statistically better differences between primary and secondary outcome rates of cardiac cases. Although there was no difference between cardiac and non-cardiac cases in terms of primary outcome, secondary outcome was statistically significant. Timing of consultation and CVVHDF was not found to have an effect on the outcome. CONCLUSION Our results indicated that CVVHDF treatment was successful even in cardiac patients with high mortality and in patients at their later stage of ARF.
Collapse
|
46
|
Cullis B, Abdelraheem M, Abrahams G, Balbi A, Cruz DN, Frishberg Y, Koch V, McCulloch M, Numanoglu A, Nourse P, Pecoits-Filho R, Ponce D, Warady B, Yeates K, Finkelstein FO. Peritoneal dialysis for acute kidney injury. Perit Dial Int 2015; 34:494-517. [PMID: 25074995 DOI: 10.3747/pdi.2013.00222] [Citation(s) in RCA: 133] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Affiliation(s)
- Brett Cullis
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USARenal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, U
| | - Mohamed Abdelraheem
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Georgi Abrahams
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Andre Balbi
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Dinna N Cruz
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Yaacov Frishberg
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Vera Koch
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Mignon McCulloch
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Alp Numanoglu
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Peter Nourse
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Roberto Pecoits-Filho
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Daniela Ponce
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Bradley Warady
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Karen Yeates
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| | - Fredric O Finkelstein
- Renal Unit, Greys Hospital, Pietermaritzburg, South Africa; Renal and Intensive Care Units, Royal Devon and Exeter Hospital, Exeter, United Kingdom; Pediatric Nephrology Unit, Soba University Hospital, University of Khartoum, Sudan; Pondicherry Institute of Medical Sciences and Madras Medical Mission, Chennai, India; Department of Medicine, Botucatu School of Medicine, Sao Paulo, Brazil; Division of Nephrology-Hypertension, University of California, San Diego, USA; Division of Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel; Pediatric Nephrology Unit, Instituto da Criança of the Hospital das Clinicas of the University of Sao Paulo Medical School, Sao Paulo, Brazil; Pediatric Nephrology Department, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; Department of Surgery, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil; Division of Pediatric Nephrology, University of Missouri-Kansas City School of Medicine, Kansas City, USA; Division of Nephrology, Queen's University, Kingston, Canada; and Yale University, New Haven, USA
| |
Collapse
|
47
|
Chang JW, Jeng MJ, Yang LY, Chen TJ, Chiang SC, Soong WJ, Wu KG, Lee YS, Wang HH, Yang CF, Tsai HL. The epidemiology and prognostic factors of mortality in critically ill children with acute kidney injury in Taiwan. Kidney Int 2015; 87:632-9. [DOI: 10.1038/ki.2014.299] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2014] [Revised: 07/19/2014] [Accepted: 07/24/2014] [Indexed: 01/07/2023]
|
48
|
Harshman LA, Muff-Luett M, Neuberger ML, Dagle JM, Shilyansky J, Nester CM, Brophy PD, Jetton JG. Peritoneal dialysis in an extremely low-birth-weight infant with acute kidney injury. Clin Kidney J 2014; 7:582-5. [PMID: 25859376 PMCID: PMC4389134 DOI: 10.1093/ckj/sfu095] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2014] [Accepted: 08/15/2014] [Indexed: 11/13/2022] Open
Abstract
Critically ill neonates are at high risk for acute kidney injury (AKI). Renal supportive therapy (RST) can be an important tool for supporting critically ill neonates with AKI, particularly in cases of oliguria and fluid overload. There are few reports of RST for management of oligo-anuric AKI in the extremely low-birth-weight infant weighing <1000 g. We report successful provision of peritoneal dialysis (PD) to an 830-g neonate with oligo-anuric AKI through adaptation of a standard pediatric acute PD catheter.
Collapse
Affiliation(s)
- Lyndsay A Harshman
- Stead Family Department of Pediatrics, Division of Pediatric Nephrology , University of Iowa Children's Hospital , Iowa City, IA , USA
| | - Melissa Muff-Luett
- Stead Family Department of Pediatrics, Division of Pediatric Nephrology , University of Iowa Children's Hospital , Iowa City, IA , USA
| | - Mary L Neuberger
- Stead Family Department of Pediatrics, Division of Pediatric Nephrology , University of Iowa Children's Hospital , Iowa City, IA , USA
| | - John M Dagle
- Stead Family Department of Pediatrics, Division of Neonatology , University of Iowa Children's Hospital , Iowa, City , IA , USA
| | - Joel Shilyansky
- Department of Surgery, Division of Pediatric Surgery , University of Iowa Carver College of Medicine , Iowa City , IA , USA
| | - Carla M Nester
- Stead Family Department of Pediatrics, Division of Pediatric Nephrology , University of Iowa Children's Hospital , Iowa City, IA , USA
| | - Patrick D Brophy
- Stead Family Department of Pediatrics, Division of Pediatric Nephrology , University of Iowa Children's Hospital , Iowa City, IA , USA
| | - Jennifer G Jetton
- Stead Family Department of Pediatrics, Division of Pediatric Nephrology , University of Iowa Children's Hospital , Iowa City, IA , USA
| |
Collapse
|
49
|
Abstract
The incidence of acute kidney injury (AKI) has steadily increased in the last decade in neonates and infants. Despite the extensive proposed pharmacologic approaches to treat or prevent AKI, renal replacement therapy is the only available therapeutic approach to manage the consequences of significant AKI and maintain electrolyte homeostasis and fluid balance in infants with AKI. The objective of this article is to summarize the different approaches and modalities of renal replacement therapy in neonatal intensive care units.
Collapse
Affiliation(s)
- Ahmad Kaddourah
- Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center (CCHMC), MLC 7022, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA
| | - Stuart L Goldstein
- Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center (CCHMC), MLC 7022, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.
| |
Collapse
|
50
|
Abstract
Critically ill neonates are at risk for acute kidney injury (AKI). AKI has been associated with increased risk of morbidity and mortality in adult and pediatric patients, and increasing evidence suggests a similar association in the neonatal population. This article describes the current AKI definitions (including their limitations), work on novel biomarkers to define AKI, diagnosis and management strategies, long-term outcomes after AKI, and future directions for much-needed research in this important area.
Collapse
|